Related Experiment Videos
Current status of MR imaging contrast agents: special report
1Pittsburgh NMR Institute, PA 15213.
Radiology
|September 1, 1989
Abstract:
The first contrast agent for magnetic resonance imaging has been available for clinical use in the United States for just over 1 year. It has been widely adopted for a variety of indications with apparent safety. Several other agents are in clinical trials and are reviewed here.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma.
The American journal of pathology·2001
Changes in vascularization of human breast cancer xenografts responding to antiestrogen therapy.
Neoplasia (New York, N.Y.)·2000
An adaptive microwave phased array for targeted heating of deep tumours in intact breast: animal study results.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·1999
Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules.
Proceedings of the National Academy of Sciences of the United States of America·1999
Transcranial Ultrasound in the Helicopter Emergency Medical Services-A Feasibility Study.
Journal of neuroimaging : official journal of the American Society of Neuroimaging·2026
Correction: Salivary exosomal Mycobacterium tuberculosis DNA enables sensitive detection of paucibacillary tuberculosis: a molecular diagnosis study.
Frontiers in cellular and infection microbiology·2026